Clinical Trials Directory

Trials / Unknown

UnknownNCT05750381

Assessment of Colonisation and Skin Quality Parameter Improvement by Probiotic Micrococcus Luteus Q24 Balm in Healthy Adults.

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
BLIS Technologies Limited · Industry
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to evaluate the skin quality improvement and colonization efficacy following the application of probiotic Micrococcus luteus Q24 (BLIS Q24) to the elbow and back of forearm in a topical balm format in healthy adults.

Detailed description

This is a randomized double-blind, placebo-controlled pilot study with no crossover for the assessment of any changes to the microbial make-up of the skin (The local skin microbiome), detection of colonisation by the probiotic bacterium (BLIS Q24) on the skin and to evaluate the changes in skin quality parameters following topical application of probiotic in a balm format.

Conditions

Interventions

TypeNameDescription
OTHERMicrococcus luteus Blis Q24 balmBalm formulation containing probiotic bacteria Micrococcus luteus Q24 for topical applications.
OTHERPlacebo balmPlacebo balm formulation for topical applications.

Timeline

Start date
2023-01-24
Primary completion
2023-03-10
Completion
2023-04-12
First posted
2023-03-01
Last updated
2023-03-01

Locations

1 site across 1 country: New Zealand

Source: ClinicalTrials.gov record NCT05750381. Inclusion in this directory is not an endorsement.